Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: Results of a nationwide survey

Transplant International

Volumn 27, Issue 8, 2014, Pages 767-774

  Akamatsu, Nobuhisa ^a   Sugawara, Yasuhiko ^a   Kokudo, Norihiro ^a   Eguchi, Susumu ^b   Fujiwara, Toshiyoshi ^c   Ohdan, Hideki ^d   Nagano, Hiroaki ^e   Taketomi, Akinobu ^f   Kitagawa, Yuko ^g   Shimada, Mitsuo ^h   Ku, Yonson ⁱ   Yanaga, Katsuhiko ^j   Shirabe, Ken ^k   Ikegami, Toru ^k   Mizokami, Masashi ^l   Takeuchi, Masahiro ^m   Maehara, Yoshihiko ^k  

^a UNIVERSITY OF TOKYO   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h UNIVERSITY OF TOKUSHIMA   (Japan)

ⁱ KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k KYUSHU UNIVERSITY   (Japan)

^l NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^m KITASATO UNIVERSITY   (Japan)

more..

Author keywords

hepatitis C virus; living donor liver transplantation; nationwide survey

Indexed keywords

PEGINTERFERON; RIBAVIRIN;

ADULT; AGED; ANTIVIRAL THERAPY; DRUG DOSE REDUCTION; FEMALE; GRAFT RECIPIENT; HEALTH CARE SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; JAPAN; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LIVING DONOR LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT INFECTION; REVIEW; SURVIVAL; TREATMENT OUTCOME; ADOLESCENT; COMPLICATION; HEPATITIS C, CHRONIC; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84904977201     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12329     Document Type: Review

References (37)

1. Singal AK, Guturu P, Hmoud B, Kuo YF, Salameh H, Wiesner RH,. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation 2013; 95: 755.
2. Adam R, Karam V, Delvart V, et al,. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol 2012; 57: 675.
3. Society TJLT. Liver transplantation in Japan. Registry by the Japanese Liver Transplantation Society. Jpn J Transpl 2011; 46: 524.
4. Gane EJ, Portmann BC, Naoumov NV, et al,. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815.
5. Berenguer M,. Natural history of recurrent hepatitis C. Liver Transpl 2002; 8 (10 Suppl. 1): S14.
6. Thuluvath PJ, Krok KL, Segev DL, Yoo HY,. Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States. Liver Transpl 2007; 13: 719.
7. Coilly A, Roche B, Dumortier J, et al,. Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience. J Hepatol 2014; 60: 78.
8. Berenguer M,. Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin. J Hepatol 2008; 49: 274.
9. van der Meer AJ, Veldt BJ, Feld JJ, et al,. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 2012; 308: 2584.
10. Gurusamy KS, Tsochatzis E, Davidson BR, Burroughs AK,. Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation. Cochrane Database Syst Rev 2010; 12: CD006573.
11. Akamatsu N, Sugawara Y,. Living-donor liver transplantation and hepatitis C. HPB Surg 2013; 2013: 985972.
12. Tamura S, Sugawara Y, Kokudo N,. Living donor liver transplantation for hepatocellular carcinoma: the Japanese experience. Oncology 2011; 81 (Suppl. 1): 111.
13. Terrault NA, Shiffman ML, Lok AS, et al,. Outcomes in hepatitis C virus-infected recipients of living donor versus deceased donor liver transplantation. Liver Transpl 2007; 13: 122.
14. Gallegos-Orozco JF, Yosephy A, Noble B, et al,. Natural history of post-liver transplantation hepatitis C: a review of factors that may influence its course. Liver Transpl 2009; 15: 1872.
15. Lake JR, Shorr JS, Steffen BJ, Chu AH, Gordon RD, Wiesner RH,. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant 2005; 5: 549.
16. Condron SL, Heneghan MA, Patel K, Dev A, McHutchison JG, Muir AJ,. Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. Transplantation 2005; 80: 145.
17. Maluf DG, Edwards EB, Stravitz RT, Kauffman HM,. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients. Liver Transpl 2009; 15: 592.
18. Wali M, Harrison RF, Gow PJ, Mutimer D,. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002; 51: 248.
19. Charlton M, Seaberg E, Wiesner R, et al,. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28: 823.
20. Sheiner PA, Schwartz ME, Mor E, et al,. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995; 21: 30.
21. Verna EC, Abdelmessih R, Salomao MA, Lefkowitch J, Moreira RK, Brown RS Jr,. Cholestatic hepatitis C following liver transplantation: an outcome-based histological definition, clinical predictors, and prognosis. Liver Transpl 2013; 19: 78.
22. Firpi RJ, Clark V, Soldevila-Pico C, et al,. The natural history of hepatitis C cirrhosis after liver transplantation. Liver Transpl 2009; 15: 1063.
23. Berenguer M, Palau A, Aguilera V, Rayon JM, Juan FS, Prieto M,. Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation. Am J Transplant 2008; 8: 679.
24. Selzner N, Renner EL, Selzner M, et al,. Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome. Transplantation 2009; 88: 1214.
25. Veldt BJ, Poterucha JJ, Watt KD, et al,. Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection. Am J Transplant 2008; 8: 2426.
26. Thuluvath PJ, Yoo HY,. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation. Liver Transpl 2004; 10: 1263.
27. Russo MW, Galanko J, Beavers K, Fried MW, Shrestha R,. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl 2004; 10: 340.
28. Selzner N, Girgrah N, Lilly L, et al,. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age. Liver Transpl 2008; 14: 1778.
29. Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS,. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up. Transplantation 2011; 92: 453.
30. Garcia-Retortillo M, Forns X, Llovet JM, et al,. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 2004; 40: 699.
31. Zimmerman MA, Trotter JF,. Living donor liver transplantation in patients with hepatitis C. Liver Transpl 2003; 9: S52.
32. Olthoff KM,. Hepatic regeneration in living donor liver transplantation. Liver Transpl 2003; 9 (10 Suppl. 2): S35.
33. Garcia-Retortillo M, Forns X, Feliu A, et al,. Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology 2002; 35: 680.
34. Akamatsu N, Sugawara Y, Tamura S, Imamura H, Kokudo N, Makuuchi M,. Regeneration and function of hemiliver graft: right versus left. Surgery 2006; 139: 765.
35. Soejima Y, Shirabe K, Taketomi A, et al,. Left lobe living donor liver transplantation in adults. Am J Transplant 2012; 12: 1877.
36. Bzowej N, Nelson DR, Terrault NA, et al,. PHOENIX: a randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus. Liver Transpl 2011; 17: 528.
37. Akamatsu N, Sugawara Y,. Liver transplantation and hepatitis C. Int J Hepatol 2012; 2012: 686135.